• About us
• Contact

Advertisement

Organisation › Details

Cepheid (US)

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation's (NYSE: DHR) Diagnostics platform. Cepheid is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. *

 

	Start	1999-09-09 existent
	Group	Danaher (Group)
	Industry	in vitro diagnostics (IVD)
	Region	Sunnyvale, CA
	Country	United States (USA)
	Street	904 Caribbean Drive
	City	94089 Sunnyvale, CA
	Tel	+1-408-541-4191
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	539,000,000 (revenues, total, consolidated (2015) 2015-12-31)
	Profit	-20,043,000 (2012-12-31)
	Cash	95,800,000 (2012-12-31)
		* Document for »About Section«: Cepheid. (21/3/20). "Press Release: Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test". Sunnyvale, CA.
		Record changed: 2023-07-10

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
• [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
• [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [7] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [8] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
• [9] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [10] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.